世界の高分子注射薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Large Molecule Injectable Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12421 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、高分子注射薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。高分子注射薬の種類別市場規模（静脈注射、筋肉注射、皮下注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・高分子注射薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Biogen、AstraZeneca、Roche、Sun Pharmaceutical、Medtronic、Novartis、​​Baxter、Amgen、Pfizer、Johnson & Johnson ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：静脈注射、筋肉注射、皮下注射 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・高分子注射薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・高分子注射薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・高分子注射薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・高分子注射薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・高分子注射薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Large Molecule Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Large Molecule Injectable Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Large Molecule Injectable Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Large Molecule Injectable Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Intravenous Injection
Muscle Injection
Subcutaneous Injection

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
Biogen
AstraZeneca
Roche
Sun Pharmaceutical
Medtronic
Novartis
​​Baxter
Amgen
Pfizer
Johnson & Johnson

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Large Molecule Injectable Drugs
1.2 Classification of Large Molecule Injectable Drugs by Type
1.2.1 Overview: Global Large Molecule Injectable Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Large Molecule Injectable Drugs Revenue Market Share by Type in 2020
1.2.3 Intravenous Injection
1.2.4 Muscle Injection
1.2.5 Subcutaneous Injection
1.3 Global Large Molecule Injectable Drugs Market by Application
1.3.1 Overview: Global Large Molecule Injectable Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Large Molecule Injectable Drugs Market Size & Forecast
1.5 Global Large Molecule Injectable Drugs Market Size and Forecast by Region
1.5.1 Global Large Molecule Injectable Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Large Molecule Injectable Drugs Market Size by Region, (2016-2021)
1.5.3 North America Large Molecule Injectable Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Large Molecule Injectable Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Large Molecule Injectable Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Large Molecule Injectable Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Large Molecule Injectable Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Large Molecule Injectable Drugs Market Drivers
1.6.2 Large Molecule Injectable Drugs Market Restraints
1.6.3 Large Molecule Injectable Drugs Trends Analysis
2 Company Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Large Molecule Injectable Drugs Product and Solutions
2.1.4 Biogen Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Biogen Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Large Molecule Injectable Drugs Product and Solutions
2.2.4 AstraZeneca Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Large Molecule Injectable Drugs Product and Solutions
2.3.4 Roche Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Roche Recent Developments and Future Plans
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Product and Solutions
2.4.4 Sun Pharmaceutical Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business
2.5.3 Medtronic Large Molecule Injectable Drugs Product and Solutions
2.5.4 Medtronic Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Medtronic Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Large Molecule Injectable Drugs Product and Solutions
2.6.4 Novartis Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis Recent Developments and Future Plans
2.7 ​​Baxter
2.7.1 ​​Baxter Details
2.7.2 ​​Baxter Major Business
2.7.3 ​​Baxter Large Molecule Injectable Drugs Product and Solutions
2.7.4 ​​Baxter Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ​​Baxter Recent Developments and Future Plans
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Large Molecule Injectable Drugs Product and Solutions
2.8.4 Amgen Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Amgen Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Large Molecule Injectable Drugs Product and Solutions
2.9.4 Pfizer Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Large Molecule Injectable Drugs Product and Solutions
2.10.4 Johnson & Johnson Large Molecule Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Large Molecule Injectable Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Large Molecule Injectable Drugs Players Market Share
3.2.2 Top 10 Large Molecule Injectable Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Large Molecule Injectable Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Large Molecule Injectable Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Large Molecule Injectable Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Large Molecule Injectable Drugs Revenue Market Share by Application (2016-2021)
5.2 Large Molecule Injectable Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Large Molecule Injectable Drugs Revenue by Type (2016-2026)
6.2 North America Large Molecule Injectable Drugs Revenue by Application (2016-2026)
6.3 North America Large Molecule Injectable Drugs Market Size by Country
6.3.1 North America Large Molecule Injectable Drugs Revenue by Country (2016-2026)
6.3.2 United States Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Large Molecule Injectable Drugs Revenue by Type (2016-2026)
7.2 Europe Large Molecule Injectable Drugs Revenue by Application (2016-2026)
7.3 Europe Large Molecule Injectable Drugs Market Size by Country
7.3.1 Europe Large Molecule Injectable Drugs Revenue by Country (2016-2026)
7.3.2 Germany Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
7.3.3 France Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Large Molecule Injectable Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Large Molecule Injectable Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region
8.3.1 Asia-Pacific Large Molecule Injectable Drugs Revenue by Region (2016-2026)
8.3.2 China Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
8.3.5 India Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Large Molecule Injectable Drugs Revenue by Type (2016-2026)
9.2 South America Large Molecule Injectable Drugs Revenue by Application (2016-2026)
9.3 South America Large Molecule Injectable Drugs Market Size by Country
9.3.1 South America Large Molecule Injectable Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Large Molecule Injectable Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Large Molecule Injectable Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country
10.3.1 Middle East & Africa Large Molecule Injectable Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Large Molecule Injectable Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Large Molecule Injectable Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Large Molecule Injectable Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Large Molecule Injectable Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Large Molecule Injectable Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Large Molecule Injectable Drugs Revenue Market Share by Region (2021-2026)
Table 6. Biogen Corporate Information, Head Office, and Major Competitors
Table 7. Biogen Major Business
Table 8. Biogen Large Molecule Injectable Drugs Product and Solutions
Table 9. Biogen Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Large Molecule Injectable Drugs Product and Solutions
Table 13. AstraZeneca Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Roche Corporate Information, Head Office, and Major Competitors
Table 15. Roche Major Business
Table 16. Roche Large Molecule Injectable Drugs Product and Solutions
Table 17. Roche Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Sun Pharmaceutical Major Business
Table 20. Sun Pharmaceutical Large Molecule Injectable Drugs Product and Solutions
Table 21. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Medtronic Corporate Information, Head Office, and Major Competitors
Table 23. Medtronic Major Business
Table 24. Medtronic Large Molecule Injectable Drugs Product and Solutions
Table 25. Medtronic Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Large Molecule Injectable Drugs Product and Solutions
Table 29. Novartis Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ​​Baxter Corporate Information, Head Office, and Major Competitors
Table 31. ​​Baxter Major Business
Table 32. ​​Baxter Large Molecule Injectable Drugs Product and Solutions
Table 33. ​​Baxter Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Amgen Corporate Information, Head Office, and Major Competitors
Table 35. Amgen Major Business
Table 36. Amgen Large Molecule Injectable Drugs Product and Solutions
Table 37. Amgen Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Large Molecule Injectable Drugs Product and Solutions
Table 41. Pfizer Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Large Molecule Injectable Drugs Product and Solutions
Table 45. Johnson & Johnson Large Molecule Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Large Molecule Injectable Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Large Molecule Injectable Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Large Molecule Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Large Molecule Injectable Drugs Players Head Office, Products and Services Provided
Table 50. Large Molecule Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Large Molecule Injectable Drugs New Entrants and Expansion Plans
Table 52. Global Large Molecule Injectable Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Large Molecule Injectable Drugs Revenue Share by Type (2016-2021)
Table 54. Global Large Molecule Injectable Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Large Molecule Injectable Drugs Revenue by Application (2016-2021)
Table 56. Global Large Molecule Injectable Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Large Molecule Injectable Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Large Molecule Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Large Molecule Injectable Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Large Molecule Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Large Molecule Injectable Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Large Molecule Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Large Molecule Injectable Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Large Molecule Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Large Molecule Injectable Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Large Molecule Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Large Molecule Injectable Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Large Molecule Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Large Molecule Injectable Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Large Molecule Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Large Molecule Injectable Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Large Molecule Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Large Molecule Injectable Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Large Molecule Injectable Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Large Molecule Injectable Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Large Molecule Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Large Molecule Injectable Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Large Molecule Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Large Molecule Injectable Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Large Molecule Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Large Molecule Injectable Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Large Molecule Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Large Molecule Injectable Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Large Molecule Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Large Molecule Injectable Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Large Molecule Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Large Molecule Injectable Drugs Picture
Figure 2. Global Large Molecule Injectable Drugs Revenue Market Share by Type in 2020
Figure 3. Intravenous Injection
Figure 4. Muscle Injection
Figure 5. Subcutaneous Injection
Figure 6. Large Molecule Injectable Drugs Revenue Market Share by Application in 2020
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Large Molecule Injectable Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Large Molecule Injectable Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Large Molecule Injectable Drugs Revenue Market Share by Region (2016-2026)
Figure 13. Global Large Molecule Injectable Drugs Revenue Market Share by Region in 2020
Figure 14. North America Large Molecule Injectable Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Large Molecule Injectable Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Large Molecule Injectable Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Large Molecule Injectable Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Large Molecule Injectable Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Large Molecule Injectable Drugs Market Drivers
Figure 20. Large Molecule Injectable Drugs Market Restraints
Figure 21. Large Molecule Injectable Drugs Market Trends
Figure 22. Biogen Recent Developments and Future Plans
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. Roche Recent Developments and Future Plans
Figure 25. Sun Pharmaceutical Recent Developments and Future Plans
Figure 26. Medtronic Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. ​​Baxter Recent Developments and Future Plans
Figure 29. Amgen Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. Global Large Molecule Injectable Drugs Revenue Share by Players in 2020
Figure 33. Large Molecule Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Large Molecule Injectable Drugs Revenue Market Share in 2020
Figure 35. Global Top 10 Players Large Molecule Injectable Drugs Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Large Molecule Injectable Drugs Revenue Share by Type in 2020
Figure 38. Global Large Molecule Injectable Drugs Market Share Forecast by Type (2021-2026)
Figure 39. Global Large Molecule Injectable Drugs Revenue Share by Application in 2020
Figure 40. Global Large Molecule Injectable Drugs Market Share Forecast by Application (2021-2026)
Figure 41. North America Large Molecule Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 42. North America Large Molecule Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 43. North America Large Molecule Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 44. United States Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Large Molecule Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 48. Europe Large Molecule Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 49. Europe Large Molecule Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Large Molecule Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Large Molecule Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Large Molecule Injectable Drugs Revenue Market Share by Region (2016-2026)
Figure 58. China Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Large Molecule Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 65. South America Large Molecule Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Large Molecule Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Large Molecule Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Large Molecule Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Large Molecule Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Large Molecule Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---